In pancreatic tissue of T1D patients, Necl-2 is highly expressed by pancreatic islet cells and myeloid cells in the proximity of CD8+ T lymphocytes, which suggests their susceptibility for CRTAM-mediated cytotoxicity and promotes T-cell–APC interactions, respectively [74]. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.